Loading...

Lisa Bero, PhD

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-1067
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    UCSF, Academic Senate2009Distinction in Mentoring Award
    Philip R. Lee Institute for Health Policy Studies, UCSF2009Harold Luft Award for Mentoring in Health Services and Health Policy Research
    McMaster University1998LaBelle Lectureship

    Collapse Overview 
    Collapse Overview
    Lisa A. Bero, PhD, Professor, Department of Clinical Pharmacy, School of Pharmacy and Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco and chemicals. Dr. Bero has also conducted analyses to examine the dissemination and policy implications of research evidence. Her international activities include advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies, member and chair of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Director of the San Francisco Branch of the United States Cochrane Center and the World Health Organization Collaborating Centre on Pharmaceutical Research and Science Policy. She was an elected member of the Cochrane Collaboration Steering Group for 12 years and was appointed Co-Chair in 2013. Dr. Bero serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.

    Collapse Research 
    Collapse Research Activities and Funding
    Measuring Design, Reporting and Funding Bias in Nonclinical Research
    NIH R21ES021028Sep 1, 2011 - Jul 31, 2014
    Role: Principal Investigator
    A Qualitative Study of Editorial Decision-Making
    NIH R01NS044500Sep 15, 2002 - Aug 31, 2005
    Role: Principal Investigator
    Management Decisions in Financial Conflicts of Interest
    NIH R01NS042398Sep 1, 2001 - Jul 31, 2004
    Role: Principal Investigator
    DEVELOPING POLICY TO REVERSE THE CIGAR TREND
    NIH R01CA076972Sep 30, 1997 - Sep 29, 2001
    Role: Principal Investigator
    MOLECULAR CHARACTERIZATION OF OPIATE BINDING SITES
    NIH F32DA005327Feb 1, 1988
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020 12 09; 371:m4234. Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. PMID: 33298430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev. 2020 Dec 08; 12:MR000040. Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. PMID: 33289919.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Understanding professional stakeholders' active resistance to guideline implementation: The case of Canadian breast screening guidelines. Soc Sci Med. 2020 Dec 05; 269:113586. Wang Z, Bero L, Grundy Q. PMID: 33333377.
      View in: PubMed   Mentions:    Fields:    
    4. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2020 Dec 04; 10(12):e039036. Chartres N, Fabbri A, McDonald S, Diong J, McKenzie JE, Bero L. PMID: 33277278.
      View in: PubMed   Mentions:    Fields:    
    5. Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines. BMC Public Health. 2020 Nov 23; 20(1):1758. Wang Z, Grundy Q, Parker L, Bero L. PMID: 33228608.
      View in: PubMed   Mentions:    Fields:    
    6. Policy makers must act on incomplete evidence in responding to COVID-19. Cochrane Database Syst Rev. 2020 11 20; 11:ED000149. Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. PMID: 33215686.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. Am J Public Health. 2020 11; 110(11):1601-1602. Bero LA. PMID: 33026865.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    8. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. Br J Clin Pharmacol. 2020 Oct 31. Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. PMID: 33129226.
      View in: PubMed   Mentions:    Fields:    
    9. Digital contact tracing technologies in epidemics: a rapid review. Cochrane Database Syst Rev. 2020 08 18; 8:CD013699. Anglemyer A, Moore TH, Parker L, Chambers T, Grady A, Chiu K, Parry M, Wilczynska M, Flemyng E, Bero L. PMID: 33502000.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    10. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly-available disclosures. Intern Med J. 2020 Aug 03. Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. PMID: 32744396.
      View in: PubMed   Mentions:    Fields:    
    11. "It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. Int J Health Policy Manag. 2020 08 01; 9(8):335-343. Chartres N, Grundy Q, Parker LM, Bero LA. PMID: 32610737.
      View in: PubMed   Mentions:    Fields:    
    12. Creating effective interrupted time series graphs: Review and recommendations. Res Synth Methods. 2021 Jan; 12(1):106-117. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, Cheng AC, Bero L, McKenzie JE. PMID: 32657532.
      View in: PubMed   Mentions: 1     Fields:    
    13. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020 07 19; 10(7):e034082. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. PMID: 32690498.
      View in: PubMed   Mentions: 1     Fields:    
    14. Commercial influence and covid-19. BMJ. 2020 06 24; 369:m2456. Moynihan R, Macdonald H, Bero L, Godlee F. PMID: 32580930.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    15. Comparison of methodological quality between the 2007 and 2019 Canadian dietary guidelines. Public Health Nutr. 2020 11; 23(16):2879-2885. Dai Z, Kroeger CM, Lawrence M, Scrinis G, Bero L. PMID: 32552917.
      View in: PubMed   Mentions:    Fields:    
    16. Using interactive data visualization to facilitate user selection and comparison of risk of bias tools for observational studies of exposures. Environ Int. 2020 09; 142:105806. Taylor KW, Wang Z, Walker VR, Rooney AA, Bero LA. PMID: 32505018.
      View in: PubMed   Mentions:    Fields:    Translation:PHPublic Health
    17. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ. 2020 05 27; 369:m1505. Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. PMID: 32461201.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. Am J Public Health. 2020 07; 110(7):952-953. Bero LA. PMID: 32407142.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    19. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open. 2020 05 11; 10(5):e035633. Turner K, Carboni-Jiménez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. PMID: 32398334.
      View in: PubMed   Mentions:    Fields:    
    20. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ Open. 2020 05 10; 10(5):e034195. Moynihan R, Fabbri A, Parker L, Bero L. PMID: 32393611.
      View in: PubMed   Mentions:    Fields:    
    21. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth. 2020 May; 18(5):1124-1134. Chiu K, McDonald S, Legg T, Karanges EA, Bero L. PMID: 32813367.
      View in: PubMed   Mentions:
    22. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Account Res. 2020 05; 27(4):212-237. Grundy Q, Mazzarello S, Bero L. PMID: 32233796.
      View in: PubMed   Mentions:    Fields:    
    23. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Syst Rev. 2020 04 08; 9(1):77. Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. PMID: 32268911.
      View in: PubMed   Mentions:    Fields:    
    24. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2020 Mar 27. Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. PMID: 32220937.
      View in: PubMed   Mentions:    Fields:    
    25. Improving researchers' conflict of interest declarations. BMJ. 2020 Mar 11; 368:m422. Grundy Q, Dunn AG, Bero L. PMID: 32161006.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Correction: Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PLoS One. 2020; 15(3):e0230469. Mandrioli D, Kearns CE, Bero LA. PMID: 32155228.
      View in: PubMed   Mentions:    Fields:    
    27. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Aust J Gen Pract. 2020 03; 49(3):151-154. Karanges EA, Ting N, Parker L, Fabbri A, Bero L. PMID: 32113215.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020 Jun; 122:1-11. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. PMID: 32109503.
      View in: PubMed   Mentions: 2     Fields:    
    29. IADR and AADR applaud the Lancet Oral Health Series - Authors' reply. Lancet. 2020 02 22; 395(10224):564. Kearns CE, Watt RG, Bero LA, Benzian H. PMID: 32087791.
      View in: PubMed   Mentions:    Fields:    
    30. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol. F1000Res. 2020; 9:110. Korevaar E, Karahalios A, Forbes AB, Turner SL, McDonald S, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. PMID: 33163155.
      View in: PubMed   Mentions:    Fields:    
    31. Duplicate and salami publication: a prevalence study of journal policies. Int J Epidemiol. 2020 02 01; 49(1):281-288. Ding D, Nguyen B, Gebel K, Bauman A, Bero L. PMID: 32244256.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst. 2020 01 01; 112(1):30-37. Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Le Curieux F, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, El Ghissassi F, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP. PMID: 31498409.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsPHPublic Health
    33. Private food safety standards in the global food supply chain: a scoping review protocol. JBI Evid Synth. 2020 01; 18(1):97-107. Trevena H, Reeve B, Bero L, Thow AM. PMID: 31389853.
      View in: PubMed   Mentions:
    34. Conflict of interest as ethical shorthand: understanding the range and nature of "non-financial conflict of interest" in biomedicine. J Clin Epidemiol. 2020 04; 120:1-7. Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. PMID: 31866470.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. The SSSPIN study-spin in studies of spin: meta-research analysis. BMJ. 2019 Dec 18; 367:l6202. Bero L, Chiu K, Grundy Q. PMID: 31852680.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 2020 02; 135:105039. Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schlünssen V, Sgargi D, Silbergeld EK, Sørensen K, Sutton P, Tenkate T, Torreão Corrêa da Silva D, Ujita Y, van Deventer E, Woodruff TJ, Mandrioli D. PMID: 31864023.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    37. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ. 2019 12 12; 367:l6694. Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. PMID: 31831471.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Response to Soares et al. Eur J Clin Nutr. 2020 02; 74(2):351-352. Bero L, Hróbjartsson A, Grundy Q. PMID: 31822820.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Cochrane Sustainable Healthcare: evidence for action on too much medicine. Cochrane Database Syst Rev. 2019 12 06; 12:ED000143. Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, Moynihan R. PMID: 31808554.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative study. Health Res Policy Syst. 2019 Dec 05; 17(1):96. Wang Z, Grundy Q, Parker L, Bero L. PMID: 31805956.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Pathways to independence: towards producing and using trustworthy evidence. BMJ. 2019 Dec 03; 367:l6576. Moynihan R, Bero L, Hill S, Johansson M, Lexchin J, Macdonald H, Mintzes B, Pearson C, Rodwin MA, Stavdal A, Stegenga J, Thombs BD, Thornton H, Vandvik PO, Wieseler B, Godlee F. PMID: 31796508.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. J Gen Intern Med. 2019 12; 34(12):2833-2841. Grundy Q, Chiu K, Bero L. PMID: 31529374.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Methodological quality of public health guideline recommendations on vitamin D and calcium : a systematic review protocol. BMJ Open. 2019 11 07; 9(11):e031840. Dai Z, Kroeger CM, McDonald S, Page MJ, McKenzie JE, Allman-Farinelli M, Raubenheimer D, Bero L. PMID: 31699738.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    44. How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests? Environ Health. 2019 11 04; 18(1):93. Baur X, Soskolne CL, Bero LA. PMID: 31684947.
      View in: PubMed   Mentions: 1     Fields:    
    45. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. Obstet Gynecol. 2019 11; 134(5):1115-1117. Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, De Fiore L, Deyo RA, Elshaug A, Farquhar C, Fatovich DM, Fingerman E, Gérvas J, Gøtzsche PC, Gracia R, Heath I, Himmelstein DU, Hoffman JR, Järvinen T, Jureidini J, Kotaska A, Kuehlein T, Lenzer J, Levenstein S, Lexchin J, Mintzes B, Naudet F, Niquette M, Orellana Navarrete LP, Pearson CA, Rail G, Roberts R, Shah N, Sharav V, Siwek J, Topolski S, Tsai AC. PMID: 31651818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Investigation of Risk Of Bias due to Unreported and SelecTively included results in meta-analyses of nutrition research: the ROBUST study protocol. F1000Res. 2019; 8:1760. Page MJ, Bero L, Kroeger CM, Dai Z, McDonald S, Forbes A, McKenzie JE. PMID: 32117567.
      View in: PubMed   Mentions:    Fields:    
    47. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Database System Rev Implement Rep. 2019 Oct 05. Chiu K, McDonald S, Legg T, Karanges EA, Bero L. PMID: 31592835.
      View in: PubMed   Mentions:    Fields:    
    48. Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017). Int Health. 2019 09 02; 11(5):379-402. McDonald S, Fabbri A, Parker L, Williams J, Bero L. PMID: 30916303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study. BMJ Open. 2019 08 20; 9(8):e030253. Behdarvand B, Karanges EA, Bero L. PMID: 31434780.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform. Lancet. 2019 07 20; 394(10194):194-196. Kearns CE, Bero LA. PMID: 31327353.
      View in: PubMed   Mentions: 1     Fields:    
    51. Response to Acquavella J, conflict of interest: a hazard for epidemiology. Ann Epidemiol. 2019 08; 36:62-63. Soskolne CL, Advani S, Sass J, Bero LA, Ruff K. PMID: 31401133.
      View in: PubMed   Mentions: 1     Fields:    
    52. Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians. JAMA Intern Med. 2019 Jun 10. Karanges EA, Grundy Q, Bero L. PMID: 31180446.
      View in: PubMed   Mentions:    Fields:    
    53. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2019 05 19; 9(5):e022912. Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L. PMID: 31110080.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    54. Making nutrition guidelines fit for purpose. BMJ. 2019 Apr 16; 365:l1579. Bero LA, Norris SL, Lawrence MA. PMID: 30992263.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Commercial interests, transparency, and independence: a call for submissions. BMJ. 2019 Apr 16; 365:l1706. Moynihan R, Macdonald H, Heneghan C, Bero L, Godlee F. PMID: 30992258.
      View in: PubMed   Mentions: 3     Fields:    
    56. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. BMJ. 2019 03 20; 364:l920. Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R. PMID: 30894349.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    57. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena. Int J Health Policy Manag. 2019 03 01; 8(3):168-176. Parker L, Bero L, Gillies D, Raven M, Grundy Q. PMID: 30980633.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    58. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. BMJ Open. 2019 02 19; 9(2):e024928. Parker L, Karanges EA, Bero L. PMID: 30782921.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ Open. 2019 02 05; 9(2):e025864. Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. PMID: 30813119.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review. BMJ Open. 2019 01 28; 9(1):e024096. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. PMID: 30696676.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    61. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Syst Rev. 2018 12 21; 7(1):242. Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ. PMID: 30577874.
      View in: PubMed   Mentions: 10     Fields:    Translation:PHPublic Health
    62. A review of methods used for hazard identification and risk assessment of environmental hazards. Environ Int. 2019 02; 123:231-239. Chartres N, Bero LA, Norris SL. PMID: 30537638.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    63. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors. BMJ. 2018 Oct 03; 363:k3654. Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A. PMID: 30282703.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review. Am J Public Health. 2018 11; 108(11):e9-e16. Fabbri A, Lai A, Grundy Q, Bero LA. PMID: 30252531.
      View in: PubMed   Mentions: 7     Fields:    
    65. Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence. Tob Control. 2019 11; 28(6):712-718. van der Eijk Y, Bero LA, Malone RE. PMID: 30242044.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutr. 2018 12; 21(18):3422-3430. Fabbri A, Holland TJ, Bero LA. PMID: 30157979.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    67. Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Med. 2018 10; 44(10):1603-1612. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. PMID: 30132025.
      View in: PubMed   Mentions: 7     Fields:    
    68. Conflicts of Interest in Nutrition Research. JAMA. 2018 07 03; 320(1):93-94. Bero L, Grundy Q. PMID: 29971390.
      View in: PubMed   Mentions:    Fields:    
    69. Mental Health Messages in Prominent Mental Health Apps. Ann Fam Med. 2018 07; 16(4):338-342. Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q. PMID: 29987082.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Ten tips for spotting industry involvement in science policy. Tob Control. 2019 01; 28(1):1-2. Bero L. PMID: 29941543.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    71. Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. PLoS Biol. 2018 06; 16(6):e2005761. de Rezende LFM, Rey-López JP, de Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L. PMID: 29912869.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    72. Interpreting evidence in general practice: Bias and conflicts of interest. Aust J Gen Pract. 2018 06; 47(6):337-340. Parker L, Grundy Q, Bero L. PMID: 29966180.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. The advantages and limitations of guideline adaptation frameworks. Implement Sci. 2018 05 29; 13(1):72. Wang Z, Norris SL, Bero L. PMID: 29843737.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    74. Not All Influences on Science Are Conflicts of Interest. Am J Public Health. 2018 05; 108(5):632-633. Bero LA, Grundy Q. PMID: 29617619.
      View in: PubMed   Mentions: 1     Fields:    
    75. Ethical drug marketing criteria for the 21st century. BMJ. 2018 Apr 30; 361:k1809. Parker L, Williams J, Bero L. PMID: 29712644.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    76. Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust. PLoS Biol. 2018 04; 16(4):e2005972. Bero L. PMID: 29608562.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines. Nutr Rev. 2018 04 01; 76(4):290-300. Blake P, Durão S, Naude CE, Bero L. PMID: 29425371.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    78. Essential medicines availability is still suboptimal in many countries: a scoping review. J Clin Epidemiol. 2018 06; 98:41-52. Mahmic-Kaknjo M, Jelicic-Kadic A, Utrobicic A, Chan K, Bero L, Marušic A. PMID: 29452222.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open. 2018 02 13; 8(2):e019027. Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. PMID: 29440213.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. JAMA. 2018 01 23; 319(4):408-409. Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L. PMID: 29362787.
      View in: PubMed   Mentions: 4     Fields:    
    81. Getting the systematic review basics right helps clinical practice: 4 common pitfalls for systematic review authors to avoid. Br J Sports Med. 2019 Jan; 53(1):6-8. Bero L. PMID: 29217534.
      View in: PubMed   Mentions:    Fields:    
    82. Developing reliable dietary guidelines. BMJ. 2017 11 03; 359:j4845. Bero L. PMID: 29101096.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. A Social Network Analysis of the Financial Links Backing Health and Fitness Apps. Am J Public Health. 2017 11; 107(11):1783-1788. Grundy Q, Held F, Bero L. PMID: 28933939.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. 'Spin' in published biomedical literature: A methodological systematic review. PLoS Biol. 2017 Sep; 15(9):e2002173. Chiu K, Grundy Q, Bero L. PMID: 28892482.
      View in: PubMed   Mentions: 17     Fields:    
    85. Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity. Public Health Nutr. 2017 Dec; 20(17):3193-3199. Fabbri A, Chartres N, Bero LA. PMID: 28851466.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open. 2017 06 30; 7(6):e016701. Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. PMID: 28667226.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    87. Tracing the Potential Flow of Consumer Data: A Network Analysis of Prominent Health and Fitness Apps. J Med Internet Res. 2017 06 28; 19(6):e233. Grundy Q, Held FP, Bero LA. PMID: 28659254.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. Medicine shortages in Fiji: A qualitative exploration of stakeholders' views. PLoS One. 2017; 12(6):e0178429. Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, Moles RJ. PMID: 28582409.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom. 2017; 86(3):168-170. Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L. PMID: 28490018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Addressing Bias and Conflict of Interest Among Biomedical Researchers. JAMA. 2017 May 02; 317(17):1723-1724. Bero L. PMID: 28464166.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    91. Toward a Healthier Patient Voice: More Independence, Less Industry Funding. JAMA Intern Med. 2017 03 01; 177(3):350-351. Moynihan R, Bero L. PMID: 28114596.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738. Apollonio DE, Bero LA. PMID: 28219958.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 02 16; 2:MR000033. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. PMID: 28207928.
      View in: PubMed   Mentions: 116     Fields:    
    94. The ties that bind. BMJ. 2017 Jan 17; 356:j176. Lundh A, Bero L. PMID: 28096082.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest. PLoS Biol. 2016 Dec; 14(12):e2001221. Bero LA, Grundy Q. PMID: 28002462.
      View in: PubMed   Mentions: 15     Fields:    
    96. Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public Health Nutr. 2017 May; 20(7):1306-1313. Fabbri A, Chartres N, Scrinis G, Bero LA. PMID: 27989264.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Dec 01; 176(12):1769-1777. Chartres N, Fabbri A, Bero LA. PMID: 27802480.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    98. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274. Apollonio D, Philipps R, Bero L. PMID: 27878808.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    99. A call to action to reshape evidence synthesis and use for nutrition policy. Cochrane Database Syst Rev. 2016 Nov 21; 11:ED000118. Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T. PMID: 27883192.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Systematic Review: A Method at Risk for Being Corrupted. Am J Public Health. 2017 Jan; 107(1):93-96. Bero L. PMID: 27854519.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    101. The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner? JAMA Intern Med. 2016 11 01; 176(11):1718-1720. Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. PMID: 27617386.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. GRADE Methods for Guideline Development: Time to Evolve? Ann Intern Med. 2016 Dec 06; 165(11):810-811. Norris SL, Bero L. PMID: 27654340.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    103. Challenges in Assessing Mobile Health App Quality: A Systematic Review of Prevalent and Innovative Methods. Am J Prev Med. 2016 12; 51(6):1051-1059. Grundy QH, Wang Z, Bero LA. PMID: 27659122.
      View in: PubMed   Mentions: 26     Fields:    
    104. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PLoS One. 2016; 11(9):e0162198. Mandrioli D, Kearns CE, Bero LA. PMID: 27606602.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    105. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822. Apollonio DE, Wolfe N, Bero LA. PMID: 27539238.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    106. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environ Health. 2016 07 14; 15(1):74. Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rudén C. PMID: 27412149.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    107. Implementation plans included in World Health Organisation guidelines. Implement Sci. 2016 05 20; 11(1):76. Wang Z, Norris SL, Bero L. PMID: 27207104.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    108. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141. Apollonio DE, Bero LA. PMID: 27721899.
      View in: PubMed   Mentions:
    109. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environ Int. 2016 Jul-Aug; 92-93:716-28. Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ. PMID: 27156197.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    110. Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry. Ann Intern Med. 2016 06 07; 164(11):733-9. Grundy Q, Bero LA, Malone RE. PMID: 27043976.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    111. GRADE: Assessing the quality of evidence in environmental and occupational health. Environ Int. 2016 Jul-Aug; 92-93:611-6. Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, Sutton P, Wolfe MS, Woodruff TJ, Verbeek JH, Holloway AC, Santesso N, Schünemann HJ. PMID: 26827182.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    112. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environ Int. 2016 Jul-Aug; 92-93:597-604. Bero L, Anglemyer A, Vesterinen H, Krauth D. PMID: 26694022.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsPHPublic Health
    113. Big Tobacco and Drugstore Chains: A Long, Cozy Relationship. JAMA Oncol. 2015 Dec; 1(9):1215-6. Tuller D, Bero L. PMID: 26355634.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Informatics: Make sense of health data. Nature. 2015 Nov 05; 527(7576):31-2. Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I. PMID: 26536942.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    115. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. J Clin Epidemiol. 2016 Feb; 70:111-22. Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH. PMID: 26399903.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    116. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. BMJ. 2015 Jun 10; 350:h2613. Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. PMID: 26063311.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    117. Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: An Ishikawa framework. J Glob Health. 2015 Jun; 5(1):010406. Tran DN, Bero LA. PMID: 25969730.
      View in: PubMed   Mentions: 4     Fields:    
    118. Public Opinions about Overdiagnosis: A National Community Survey. PLoS One. 2015; 10(5):e0125165. Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. PMID: 25992887.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    119. Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev. 2015 Apr 20; 4:ED000098. Schroll J, Bero L. PMID: 25904511.
      View in: PubMed   Mentions: 5     Fields:    
    120. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proc Natl Acad Sci U S A. 2015 Mar 31; 112(13):E1512. Siler K, Lee K, Bero L. PMID: 25759436.
      View in: PubMed   Mentions:    Fields:    
    121. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. BMC Med Res Methodol. 2015 Mar 06; 15:12. Anglemyer AT, Krauth D, Bero L. PMID: 25880564.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    122. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015 Jun; 119(6):802-13. Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. PMID: 25791166.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    123. Expensive medicines: ensuring objective appraisal and equitable access. Bull World Health Organ. 2015 Jan 01; 93(1):4. Hill SR, Bero L, McColl G, Roughead E. PMID: 25558099.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    124. Measuring the effectiveness of scientific gatekeeping. Proc Natl Acad Sci U S A. 2015 Jan 13; 112(2):360-5. Siler K, Lee K, Bero L. PMID: 25535380.
      View in: PubMed   Mentions: 28     Fields:    
    125. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. J Clin Epidemiol. 2016 Apr; 72:98-106. Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, Guyatt GH. PMID: 25618534.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    126. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev. 2014 Nov 18; 3:122. Forsyth SR, Odierna DH, Krauth D, Bero LA. PMID: 25417178.
      View in: PubMed   Mentions: 6     Fields:    
    127. Bias related to funding source in statin trials. BMJ. 2014 Oct 03; 349:g5949. Bero L. PMID: 25281682.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect. 2014 Oct; 122(10):A262-3. Fox DM, Bero L. PMID: 25272205.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    129. On WHO's essential medicines process and transparency. BMJ. 2014 Sep 17; 349:g5637. Magrini N, Robertson J, de Joncheere K, Bero L. PMID: 25231094.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    130. A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev. 2014 Sep 15; (9):ED000090. Formoso G, Marata AM, Magrini N, Bero L. PMID: 25228121.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    131. The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. J Clin Epidemiol. 2015 Jan; 68(1):102-7. Schroll JB, Abdel-Sattar M, Bero L. PMID: 25150193.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    132. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. J Clin Epidemiol. 2014 Nov; 67(11):1239-41. Bero L. PMID: 25132356.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    133. Side effects are incompletely reported among systematic reviews in gastroenterology. J Clin Epidemiol. 2015 Feb; 68(2):144-53. Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. PMID: 25124168.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    134. Evidence based medicine: looking forward and building on what we have learnt. BMJ. 2014 Jul 09; 349:g4508. Tovey D, Churchill R, Bero L. PMID: 25008476.
      View in: PubMed   Mentions: 1     Fields:    
    135. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev. 2014 Apr 29; (4):MR000034. Anglemyer A, Horvath HT, Bero L. PMID: 24782322.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    136. The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis. Evid Based Preclin Med. 2014 Apr; 1(1):11-20. Abdel-Sattar M, Krauth D, Anglemyer A, Bero L. PMID: 25642330.
      View in: PubMed   Mentions:
    137. Staff perceptions of an on-site clinical pharmacist program in an academic emergency department after one year. West J Emerg Med. 2014 Mar; 15(2):205-10. Coralic Z, Kanzaria HK, Bero L, Stein J. PMID: 24672613.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    138. Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect. 2014 Mar; 122(3):A67. Krauth D, Woodruff TJ, Bero L. PMID: 24583480.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    139. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS Biol. 2014 Jan; 12(1):e1001770. Krauth D, Anglemyer A, Philipps R, Bero L. PMID: 24465178.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    140. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol. 2014 Jun; 67(6):629-34. Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G. PMID: 24388966.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    141. Retaining Participants in Outpatient and Community-Based Health Studies: Researchers and Participants in Their Own Words. Sage Open. 2014; 4(4):1-11. Odierna DH, Bero LA. PMID: 25599003.
      View in: PubMed   Mentions:
    142. Why the Cochrane risk of bias tool should include funding source as a standard item. Cochrane Database Syst Rev. 2013 Dec 20; (12):ED000075. Bero LA. PMID: 24575439.
      View in: PubMed   Mentions: 28     Fields:    
    143. Availability, prices and affordability of essential medicines in Haiti. J Glob Health. 2013 Dec; 3(2):020405. Chahal HS, St Fort N, Bero L. PMID: 24363923.
      View in: PubMed   Mentions: 9     Fields:    
    144. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 2013 Dec 9-23; 173(22):2032-6. Neltner TG, Alger HM, O'Reilly JT, Krimsky S, Bero LA, Maffini MV. PMID: 23925593.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    145. Interactions between non-physician clinicians and industry: a systematic review. PLoS Med. 2013 Nov; 10(11):e1001561. Grundy Q, Bero L, Malone R. PMID: 24302892.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    146. Term limits and the tobacco industry. Soc Sci Med. 2014 Mar; 104:1-5. Apollonio DE, Glantz SA, Bero LA. PMID: 24581055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med. 2013 Aug; 10(8):e1001500. Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP. PMID: 23966841.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    148. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect. 2013 Sep; 121(9):985-92. Krauth D, Woodruff TJ, Bero L. PMID: 23771496.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    149. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev. 2013 May 16; 2:31. Wolfe N, Gøtzsche PC, Bero L. PMID: 23680054.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    150. Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ. 2013 Apr 23; 346:f2231. Schroll JB, Bero L, Gøtzsche PC. PMID: 23613540.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Industry sponsorship and research outcome: a Cochrane review. JAMA Intern Med. 2013 Apr 08; 173(7):580-1. Bero L. PMID: 23440226.
      View in: PubMed   Mentions: 22     Fields:    
    152. Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med. 2013 Mar 11; 173(5):338-43. Nguyen NY, Bero L. PMID: 23400249.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013 Feb 28; (2):CD010398. Pande S, Hiller JE, Nkansah N, Bero L. PMID: 23450614.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    154. Review of the quality of pediatric medications in developing countries. J Pharm Sci. 2013 May; 102(5):1419-33. Conway J, Bero L, Ondari C, Wasan KM. PMID: 23450511.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    155. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Account Res. 2013; 20(2):127-41. Odierna DH, Forsyth SR, White J, Bero LA. PMID: 23432773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    156. Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners. Health Expect. 2015 Apr; 18(2):273-87. Odierna DH, White J, Forsyth S, Bero LA. PMID: 23252397.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    157. Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res. 2012 Dec 13; 12:455. Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L. PMID: 23234504.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    158. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 Dec 12; 12:MR000033. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. PMID: 23235689.
      View in: PubMed   Mentions: 195     Fields:    
    159. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr. 2012 Dec 01; 12:1-10. Apollonio D, Philipps R, Bero L. PMID: 23833567.
      View in: PubMed   Mentions:
    160. Measuring the performance of the Cochrane library. Cochrane Database Syst Rev. 2012 Nov 14; 12:ED000048. Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Smith R, Tovey D. PMID: 23235688.
      View in: PubMed   Mentions: 5     Fields:    
    161. The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines. J Clin Epidemiol. 2013 Feb; 66(2):132-9. Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J. PMID: 22974497.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    162. The Cochrane Collaboration review prioritization projects show that a variety of approaches successfully identify high-priority topics. J Clin Epidemiol. 2013 May; 66(5):472-3. Bero LA, Binder L. PMID: 22959591.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    163. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ. 2012 Aug 16; 345:e5155. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. PMID: 22906823.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    164. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health. 2012 Jul 02; 8:22. Anson A, Ramay B, de Esparza AR, Bero L. PMID: 22747646.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    165. Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One. 2012; 7(5):e38055. Hill S, Yang A, Bero L. PMID: 22675435.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    166. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol. 2012 Jul; 65(7):725-33. Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, Schünemann H, Deyo R. PMID: 22498428.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    167. Tobacco industry denormalisation as a tobacco control intervention: a review. Tob Control. 2012 Mar; 21(2):162-70. Malone RE, Grundy Q, Bero LA. PMID: 22345240.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    168. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012 Jan 03; 344:d7202. Hart B, Lundh A, Bero L. PMID: 22214754.
      View in: PubMed   Mentions: 54     Fields:    
    169. Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies. Environ Health Perspect. 2011 Dec; 119(12):A506-7; author reply A508-9. Sutton P, Woodruff TJ, Vogel S, Bero LA. PMID: 22134036.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    170. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. J Clin Epidemiol. 2011 Dec; 64(12):1331-40. Walleser S, Hill SR, Bero LA. PMID: 21775103.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    171. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Rev Panam Salud Publica. 2011 Jul; 30(1):87-96. Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. PMID: 22159656.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    172. Applying the essential medicines concept to US preferred drug lists. Am J Public Health. 2011 Aug; 101(8):1444-8. Millar TP, Wong S, Odierna DH, Bero LA. PMID: 21680927.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    173. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA. 2011 Mar 09; 305(10):1008-17. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. PMID: 21386079.
      View in: PubMed   Mentions: 42     Fields:    
    174. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):165-71. Dhruva SS, Bero LA, Redberg RF. PMID: 21364127.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    175. Making systematic reviews global. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000020. Bero LA, Ghersi D. PMID: 21833979.
      View in: PubMed   Mentions: 1     Fields:    
    176. The Cochrane Library Oversight Committee. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000021. Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P. PMID: 21833980.
      View in: PubMed   Mentions:    Fields:    
    177. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia. BMC Health Serv Res. 2010 Dec 16; 10:340. Ridge AL, Bero LA, Hill SR. PMID: 21162717.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    178. Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. Arch Intern Med. 2011 Mar 28; 171(6):534-9. Chen CE, Dhruva SS, Bero LA, Redberg RF. PMID: 21098342.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    179. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bull World Health Organ. 2010 Dec 01; 88(12):922-9. Bero L, Carson B, Moller H, Hill S. PMID: 21124717.
      View in: PubMed   Mentions: 4     Fields:    
    180. "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study. J Clin Epidemiol. 2010 Aug; 63(8):841-53. Cataldo JK, Bero LA, Malone RE. PMID: 20630333.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    181. CONSORT 2010. Lancet. 2010 Jul 24; 376(9737):229-30. Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. PMID: 20656114.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    182. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010 Jul 07; (7):CD000336. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. PMID: 20614422.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    183. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract. 2010 Apr; 18(2):88-92. Robertson J, Walkom E, Moynihan R, Bero L, Henry D. PMID: 20441117.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    184. The role of public participation in public health initiatives: an analysis of the WHO Framework Convention on Tobacco Control. Glob Public Health. 2010; 5(1):48-61. Montini T, George A, Martin-Mollard M, Bero LA. PMID: 19326277.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    185. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. JAMA. 2009 Dec 23; 302(24):2679-85. Dhruva SS, Bero LA, Redberg RF. PMID: 20040556.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    186. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 2009 Dec 16; 10:116. Rasmussen N, Lee K, Bero L. PMID: 20015404.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    187. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med. 2009 Nov 12; 361(20):1963-71. Vedula SS, Bero L, Scherer RW, Dickersin K. PMID: 19907043.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    188. Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med. 2009 Nov; 6(11):e1000128. Robertson J, Moynihan R, Walkom E, Bero L, Henry D. PMID: 19885393.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    189. The politics of smoking in federal buildings: an executive order case study. Am J Public Health. 2009 Sep; 99(9):1588-95. Cook DM, Bero LA. PMID: 19608948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    190. Evidence and argument in policymaking: development of workplace smoking legislation. BMC Public Health. 2009 Jun 17; 9:189. Apollonio DE, Bero LA. PMID: 19534777.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    191. Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One. 2009 Jun 08; 4(6):e5826. Rattinger G, Bero L. PMID: 19503811.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    192. Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations. J Clin Epidemiol. 2009 Dec; 62(12):1268-78. Odierna DH, Bero LA. PMID: 19375890.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    193. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr. 2009 Oct; 12(10):1931-7. Nkansah N, Nguyen T, Iraninezhad H, Bero L. PMID: 19254426.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    194. Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tob Control. 2009 Jun; 18(3):241-4. Kummerfeldt CE, Barnoya J, Bero L. PMID: 19211614.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    195. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings. Drug Saf. 2009; 32(11):1057-66. Cook DM, Gurugubelli RK, Bero LA. PMID: 19810777.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    196. Moral disengagement in the corporate world. Account Res. 2009 Jan-Mar; 16(1):41-74. White J, Bandura A, Bero LA. PMID: 19247852.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    197. Implementation of a workplace smoking ban in bars: the limits of local discretion. BMC Public Health. 2008 Dec 08; 8:402. Montini T, Bero LA. PMID: 19063716.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    198. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008 Nov 25; 5(11):e217; discussion e217. Rising K, Bacchetti P, Bero L. PMID: 19067477.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    199. "Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise. J Clin Epidemiol. 2008 Jul; 61(7):629-33. Bero L. PMID: 18538259.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    200. "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government. Milbank Q. 2008 Jun; 86(2):177-208. Jewell CJ, Bero LA. PMID: 18522611.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    201. Clarification of study and citation. Arch Intern Med. 2007 Dec 10; 167(22):2531; author reply 2531-2. Finley PR, Bero L. PMID: 18071185.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    202. Reporting science and conflicts of interest in the lay press. PLoS One. 2007 Dec 05; 2(12):e1266. Cook DM, Boyd EA, Grossmann C, Bero LA. PMID: 18060060.
      View in: PubMed   Mentions: 8     Fields:    
    203. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ. 2007 Dec 08; 335(7631):1202-5. Yank V, Rennie D, Bero LA. PMID: 18024482.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    204. Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions. Sci Eng Ethics. 2007 Dec; 13(4):415-35. Boyd EA, Bero LA. PMID: 18008185.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    205. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull. 2008 May; 34(3):555-67. Prochaska JJ, Hall SM, Bero LA. PMID: 17984298.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    206. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res. 2007 Nov; 9(11):1213-25. White J, Parascandola M, Bero L. PMID: 17978997.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    207. Participation and argument in legislative debate on statewide smoking restrictions. Health Res Policy Syst. 2007 Oct 22; 5:12. Apollonio DE, Lopipero P, Bero LA. PMID: 17953767.
      View in: PubMed   Mentions: 5     Fields:    
    208. The tobacco industry and the Data Quality Act. Science. 2007 Aug 17; 317(5840):898. Schick SF, Bero LA, Cook DM. PMID: 17702925.
      View in: PubMed   Mentions: 1     Fields:    
    209. WITHDRAWN: Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007 Jul 18; (2):CD000172. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. PMID: 17636612.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    210. [Shall we ban industrial funds for research?]. Epidemiol Prev. 2007 Jul-Aug; 31(4):171-4. Bero L. PMID: 18019196.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    211. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007 Jun; 4(6):e184. Bero L, Oostvogel F, Bacchetti P, Lee K. PMID: 17550302.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    212. Characteristics and impact of drug detailing for gabapentin. PLoS Med. 2007 Apr; 4(4):e134. Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. PMID: 17455990.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    213. The creation of industry front groups: the tobacco industry and "get government off our back". Am J Public Health. 2007 Mar; 97(3):419-27. Apollonio DE, Bero LA. PMID: 17267719.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    214. Evidence based medicine: increasing, not dictating, choice. BMJ. 2007 Jan 06; 334 Suppl 1:s10. Dickersin K, Straus SE, Bero LA. PMID: 17204750.
      View in: PubMed   Mentions: 16     Fields:    
    215. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health Res Policy Syst. 2006 Dec 01; 4:16. Boyd EA, Bero LA. PMID: 17140441.
      View in: PubMed   Mentions: 24     Fields:    
    216. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93. Steinman MA, Bero LA, Chren MM, Landefeld CS. PMID: 16908919.
      View in: PubMed   Mentions: 63     Fields:    
    217. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study. Clin Ther. 2006 Aug; 28(8):1231-1243. Nguyen NT, Cook DM, Bero LA. PMID: 16982301.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    218. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions. Tob Control. 2006 Aug; 15(4):323-32. Lopipero P, Bero LA. PMID: 16885582.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    219. Tobacco industry sponsorship of a book and conflict of interest. Addiction. 2006 Aug; 101(8):1202-11. Hong MK, Bero LA. PMID: 16869850.
      View in: PubMed   Mentions: 6     Fields:    
    220. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. Med J Aust. 2006 Jun 19; 184(12):621-6. Lee KP, Boyd EA, Holroyd-Leduc JM, Bacchetti P, Bero LA. PMID: 16803442.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    221. Identifying carcinogens: the tobacco industry and regulatory politics in the United States. Int J Health Serv. 2006; 36(4):747-66. Cook DM, Bero LA. PMID: 17175844.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    222. Attitudes of academic and clinical researchers toward financial ties in research: a systematic review. Sci Eng Ethics. 2005 Oct; 11(4):553-73. Glaser BE, Bero LA. PMID: 16279755.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    223. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke. Health Aff (Millwood). 2005 Jul-Aug; 24(4):994-1004. Cook DM, Tong EK, Glantz SA, Bero LA. PMID: 16136637.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    224. The limits of competing interest disclosures. Tob Control. 2005 Apr; 14(2):118-26. Bero LA, Glantz S, Hong MK. PMID: 15791022.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    225. Tobacco industry manipulation of research. Public Health Rep. 2005 Mar-Apr; 120(2):200-8. Bero LA. PMID: 15842123.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    226. Managing financial conflicts of interest in research. J Am Coll Dent. 2005; 72(2):4-9. Bero LA. PMID: 16353375.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    227. Legislating "sound science": the role of the tobacco industry. Am J Public Health. 2005; 95 Suppl 1:S20-7. Baba A, Cook DM, McGarity TO, Bero LA. PMID: 16030333.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    228. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tob Control. 2004 Dec; 13(4):362-9. Dunsby J, Bero L. PMID: 15564619.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsPHPublic Health
    229. Conflicts of interest in academic research: policies, processes, and attitudes. Account Res. 2004 Apr-Jun; 11(2):83-102. Lipton S, Boyd EA, Bero LA. PMID: 15675050.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    230. Implementation of financial disclosure policies to manage conflicts of interest. Health Aff (Millwood). 2004 Mar-Apr; 23(2):206-14. Boyd EA, Lipton S, Bero LA. PMID: 15046145.
      View in: PubMed   Mentions: 11     Fields:    
    231. Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry. Am J Public Health. 2004 Feb; 94(2):240-50. White J, Bero LA. PMID: 14759933.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    232. Creating a text data-mining application for use in public health informatics. Conf Proc IEEE Eng Med Biol Soc. 2004; 2004:3214-6. Michel MC, Bero LA, Bright T. PMID: 17270964.
      View in: PubMed   Mentions:    Fields:    
    233. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003 Sep; 23(9):1175-85. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. PMID: 14524649.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    234. Chasing the dollar: why scientists should decline tobacco industry funding. J Epidemiol Community Health. 2003 Aug; 57(8):546-8. Malone RE, Bero LA. PMID: 12883046.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    235. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med. 2003 Aug; 78(8):769-74. Boyd EA, Cho MK, Bero LA. PMID: 12915362.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    236. Systematic reviews of the effectiveness of quality improvement strategies and programmes. Qual Saf Health Care. 2003 Aug; 12(4):298-303. Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, Vale L, Zwarenstein M. PMID: 12897365.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    237. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003 May 31; 326(7400):1167-70. Lexchin J, Bero LA, Djulbegovic B, Clark O. PMID: 12775614.
      View in: PubMed   Mentions: 434     Fields:    
    238. Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule. Am J Public Health. 2003 Apr; 93(4):585-92. Bryan-Jones K, Bero LA. PMID: 12660202.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    239. Framing processes in public commentary on US federal tobacco control regulation. Soc Stud Sci. 2003 Feb; 33(1):7-44. Roth AL, Dunsby J, Bero LA. PMID: 12918520.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    240. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ. 2002 Dec 14; 325(7377):1413-6. Hong MK, Bero LA. PMID: 12480862.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    241. Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer. Pharmacotherapy. 2002 Oct; 22(10):1301-11. Beney J, Devine EB, Chow V, Ignoffo RJ, Mitsunaga L, Shahkarami M, McMillan A, Bero LA. PMID: 12389880.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    242. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002 Aug 15; 59(16):1518-26. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. PMID: 12185826.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    243. Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA. 2002 Aug 14; 288(6):738-44. Shamasunder B, Bero L. PMID: 12169078.
      View in: PubMed   Mentions: 10     Fields:    
    244. Association of journal quality indicators with methodological quality of clinical research articles. JAMA. 2002 Jun 05; 287(21):2805-8. Lee KP, Schotland M, Bacchetti P, Bero LA. PMID: 12038918.
      View in: PubMed   Mentions: 60     Fields:    
    245. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002 Jun 05; 287(21):2769-71. Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, Gøtzsche PC, Bero LA. PMID: 12038907.
      View in: PubMed   Mentions: 28     Fields:    
    246. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA. 2002 Jun 05; 287(21):2853-6. Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. PMID: 12038932.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    247. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Public Health Rep. 2002 May-Jun; 117(3):291-8. Montini T, Mangurian C, Bero LA. PMID: 12432140.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    248. The Criticism Management System for the Cochrane Library. Eval Health Prof. 2002 Mar; 25(1):98-115. Ober M, Shohara R, Rennie D, Yank V, Bero LA. PMID: 11868449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    249. High school journalists' perspectives on tobacco. J Health Commun. 2002 Mar-Apr; 7(2):139-56. Malone RE, Wenger LD, Bero LA. PMID: 12049422.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    250. Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Anal. 2002 Feb; 22(1):131-40. Schotland MS, Bero LA. PMID: 12017355.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    251. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Tob Control. 2001 Dec; 10(4):329-36. Bero LA, Montini T, Bryan-Jones K, Mangurian C. PMID: 11740023.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    252. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health. 2003; 24:267-88. Bero L. PMID: 12415145.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansPHPublic Health
    253. Cigar magazines: using tobacco to sell a lifestyle. Tob Control. 2001 Sep; 10(3):279-84. Wenger LD, Malone RE, George A, Bero LA. PMID: 11544394.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    254. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tob Control. 2001 Sep; 10(3):218-24. Montini T, Bero LA. PMID: 11544384.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    255. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001 Aug; 39(8 Suppl 2):II2-45. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA. PMID: 11583120.
      View in: PubMed   Mentions: 462     Fields:    Translation:Humans
    256. Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy. Eff Clin Pract. 2001 Jul-Aug; 4(4):157-62. Shojania KG, Bero LA. PMID: 11525102.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    257. "Educational" advertisements--I haven't seen one yet! West J Med. 2001 Jun; 174(6):395. Bero LA. PMID: 11381005.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    258. The cigar revival and the popular press: a content analysis, 1987-1997. Am J Public Health. 2001 Feb; 91(2):288-91. Wenger L, Malone R, Bero L. PMID: 11211641.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    259. Music to be born to, music to die to. BMJ. 2000 Dec 23-30; 321(7276):1577-9. Anderson J, Baum M, Bero LA, Chalmers I, Chapman S, Deary IJ, Ebrahim S, Evans M, Farrell M, Greaves D, Higginson I, Hippisley-Cox J, James B, McKenzie H, Macaulay AC, Rabow M, Smyth RL, Stores G, Wolpert L. PMID: 11124186.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    260. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation. Am J Public Health. 2000 Dec; 90(12):1926-30. Mangurian CV, Bero LA. PMID: 11111269.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    261. Assessing faculty financial relationships with industry: A case study. JAMA. 2000 Nov 01; 284(17):2209-14. Boyd EA, Bero LA. PMID: 11056592.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    262. Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000 Jun 01; 342(22):1645-50. Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. PMID: 10833211.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    263. Cigars, youth, and the Internet link. Am J Public Health. 2000 May; 90(5):790-2. Malone RE, Bero LA. PMID: 10800432.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    264. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000; (3):CD000336. Beney J, Bero LA, Bond C. PMID: 10908471.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    265. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000; (2):CD000172. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. PMID: 10796502.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    266. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000; (2):CD000336. Bero LA, Mays NB, Barjesteh K, Bond C. PMID: 10796529.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    267. Accepting commercial sponsorship. Disclosure helps--but is not a panacea. BMJ. 1999 Sep 11; 319(7211):653-4. Bero LA. PMID: 10480803.
      View in: PubMed   Mentions: 5     Fields:    
    268. Print media coverage of research on passive smoking. Tob Control. 1999; 8(3):254-60. Kennedy GE, Bero LA. PMID: 10599568.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    269. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998 Aug 15; 317(7156):465-8. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. PMID: 9703533.
      View in: PubMed   Mentions: 509     Fields:    
    270. Publication bias and research on passive smoking: comparison of published and unpublished studies. JAMA. 1998 Jul 15; 280(3):250-3. Misakian AL, Bero LA. PMID: 9676672.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsPHPublic Health
    271. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20; 279(19):1566-70. Barnes DE, Bero LA. PMID: 9605902.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansPHPublic Health
    272. Disclosure policies for gifts from industry to academic faculty. JAMA. 1998 Apr 01; 279(13):1031-2. Bero LA. PMID: 9533505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    273. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med. 1997 Jul 01; 127(1):37-42. Bero LA, Jadad AR. PMID: 9214251.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    274. Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997; 6(1):19-26. Barnes DE, Bero LA. PMID: 9176982.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    275. EUR-ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol Assess Health Care. 1997; 13(2):220-86. Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C, Freemantle N, Grilli R, Grimshaw J, Harvey E, Levi R, Marshall D, Oxman A, Pasart L, Räisänen V, Rius E, Espinas JA. PMID: 9194353.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    276. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med. 1996 Oct; 11(10):575-83. Stryer D, Bero LA. PMID: 8945688.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    277. GPs' prescribing behaviour may be affected by drug promotion. BMJ. 1996 Aug 10; 313(7053):367. Gill PS, Freemantle N, Bero L, Haaijer-Ruskamp F, Markela M, Barjesteh KP. PMID: 8760769.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    278. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996 Mar 01; 124(5):485-9. Cho MK, Bero LA. PMID: 8602706.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    279. Dear doctor ... regarding calcium channel blockers. JAMA. 1996 Feb 21; 275(7):517-9. Stryer DB, Lurie P, Bero LA. PMID: 8606469.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    280. Improving the use of information in medical effectiveness research. Int J Qual Health Care. 1996 Feb; 8(1):21-30. Phillips KA, Bero LA. PMID: 8680813.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    281. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996; 21(3):515-42. Barnes DE, Bero LA. PMID: 8784687.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansPHPublic Health
    282. Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996; 12(2):209-37. Bero LA, Rennie D. PMID: 8707496.
      View in: PubMed   Mentions: 46     Fields:    
    283. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA. 1995 Dec 27; 274(24):1935-8. Bero L, Rennie D. PMID: 8568988.
      View in: PubMed   Mentions: 48     Fields:    
    284. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study. Lancet. 1995 Dec 02; 346(8988):1454-7. de Vries TP, Henning RH, Hogerzeil HV, Bapna JS, Bero L, Kafle KK, Mabadeje Af, Santoso B, Smith AJ. PMID: 7490991.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    285. The publication of commercially supported supplements statement. Anesth Analg. 1995 Oct; 81(4):887-8; author reply 888-9. Hornbein T, Bero L, Rennie D. PMID: 7574039.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    286. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA. 1995 Jul 19; 274(3):219-24. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. PMID: 7609230.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsPHPublic Health
    287. Nicotine and addiction. The Brown and Williamson documents. JAMA. 1995 Jul 19; 274(3):225-33. Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA. PMID: 7609231.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsPHPublic Health
    288. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA. 1995 Jul 19; 274(3):241-7. Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA. PMID: 7609233.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsPHPublic Health
    289. Environmental tobacco smoke. The Brown and Williamson documents. JAMA. 1995 Jul 19; 274(3):248-53. Barnes DE, Hanauer P, Slade J, Bero LA, Glantz SA. PMID: 7609234.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsPHPublic Health
    290. Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents. JAMA. 1995 Jul 19; 274(3):234-40. Hanauer P, Slade J, Barnes DE, Bero L, Glantz SA. PMID: 7609232.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsPHPublic Health
    291. Health care cost effects of public use of a regional poison control center. West J Med. 1995 Jun; 162(6):499-504. Kearney TE, Olson KR, Bero LA, Heard SE, Blanc PD. PMID: 7618308.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    292. Drug promotion. N Engl J Med. 1995 Apr 13; 332(15):1032; author reply 1033. Stryer DB, Bero LA. PMID: 7885416.
      View in: PubMed   Mentions: 1     Fields:    
    293. Inappropriate and appropriate selection of 'peers' in grant review. JAMA. 1994 Jul 13; 272(2):114-6. Glantz SA, Bero LA. PMID: 8015118.
      View in: PubMed   Mentions: 2     Fields:    
    294. Publication bias and public health policy on environmental tobacco smoke. JAMA. 1994 Jul 13; 272(2):133-6. Bero LA, Glantz SA, Rennie D. PMID: 8015124.
      View in: PubMed   Mentions: 15     Fields:    Translation:PHPublic Health
    295. Instruments for assessing the quality of drug studies published in the medical literature. JAMA. 1994 Jul 13; 272(2):101-4. Cho MK, Bero LA. PMID: 8015115.
      View in: PubMed   Mentions: 38     Fields:    
    296. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23; 271(8):612-7. Bero LA, Galbraith A, Rennie D. PMID: 8301794.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsPHPublic Health
    297. Assessing the appropriateness of physician prescribing for geriatric outpatients. Development and testing of an instrument. J Pharm Technol. 1993 May-Jun; 9(3):107-13. Lipton HL, Bird JA, Bero LA, McPhee SJ. PMID: 10126852.
      View in: PubMed   Mentions:
    298. The publication of sponsored symposiums in medical journals. N Engl J Med. 1992 Oct 15; 327(16):1135-40. Bero LA, Galbraith A, Rennie D. PMID: 1528209.
      View in: PubMed   Mentions: 22     Fields:    
    299. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care. 1992 Jul; 30(7):646-58. Lipton HL, Bero LA, Bird JA, McPhee SJ. PMID: 1614233.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    300. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991 Oct; 29(10):989-1003. Bero LA, Lipton HL, Bird JA. PMID: 1921531.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    301. Throw it away, Sam: the controlled circulation journals. AJR Am J Roentgenol. 1990 Oct; 155(4):889-92. Rennie D, Bero LA. PMID: 2119127.
      View in: PubMed   Mentions: 4     Fields:    
    302. Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody. Mol Pharmacol. 1988 Nov; 34(5):614-20. Bero LA, Roy S, Lee NM. PMID: 2848185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    303. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat. Brain Res. 1987 Dec 15; 465(1-2):189-96. Bero LA, Lurie SN, Kuhn CM. PMID: 2894234.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    304. Perinatal effects of drugs of abuse. Fed Proc. 1987 May 15; 46(7):2446-53. Braude MC, Szeto HH, Kuhn CM, Bero L, Ignar D, Field E, Lurie S, Chasnoff IJ, Mendelson JH, Zuckerman B. PMID: 3494635.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    305. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion. J Pharmacol Exp Ther. 1987 Mar; 240(3):825-30. Bero LA, Kuhn CM. PMID: 3031276.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    306. Role of serotonin in opiate-induced prolactin secretion and antinociception in the developing rat. J Pharmacol Exp Ther. 1987 Mar; 240(3):831-6. Bero LA, Kuhn CM. PMID: 2435887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    307. Endocrine consequences of perinatal methadone exposure. NIDA Res Monogr. 1987; 78:72-94. Kuhn C, Bero L, Ignar D, Lurie S, Field E. PMID: 3123991.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    308. Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat. J Pharmacol Exp Ther. 1986 Apr; 237(1):137-42. Bero LA, Kuhn CM. PMID: 3007734.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    309. Quantitative determination of 5-hydroxytryptophan in dissected brain regions by on-line trace enrichment HPLC with electrochemical detection. Life Sci. 1984 Jul 02; 35(1):87-95. Kilts CD, Bero LA. PMID: 6610813.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    Lisa's Networks
    Concepts (659)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑